Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ernexa Therapeutics (ERNA) Preferred Shares (2016 - 2025)

Historic Preferred Shares for Ernexa Therapeutics (ERNA) over the last 15 years, with Q3 2025 value amounting to $1000.0.

  • Ernexa Therapeutics' Preferred Shares changed 0.0% to $1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $1000.0 for FY2024, which is 0.0% changed from last year.
  • Ernexa Therapeutics' Preferred Shares amounted to $1000.0 in Q3 2025, which was down 0.0% from $1000.0 recorded in Q2 2025.
  • Ernexa Therapeutics' Preferred Shares' 5-year high stood at $1000.0 during Q4 2023, with a 5-year trough of $781.0 in Q1 2021.
  • Over the past 4 years, Ernexa Therapeutics' median Preferred Shares value was $1000.0 (recorded in 2023), while the average stood at $934.3.
  • Its Preferred Shares has fluctuated over the past 5 years, first tumbled by 2190.0% in 2021, then changed by 0.0% in 2024.
  • Quarter analysis of 4 years shows Ernexa Therapeutics' Preferred Shares stood at $781.0 in 2021, then rose by 28.04% to $1000.0 in 2023, then changed by 0.0% to $1000.0 in 2024, then changed by 0.0% to $1000.0 in 2025.
  • Its Preferred Shares was $1000.0 in Q3 2025, compared to $1000.0 in Q2 2025 and $1000.0 in Q1 2025.